Table I.
Demographic characteristics of ALLIFE participants.
| Characteristic | Females | Males | P |
|---|---|---|---|
| N=64 % | N=52 % | ||
| Age at study | 0.47 | ||
|
| |||
| 18–24 y | 59 | 69 | |
| 25–34 y | 38 | 37 | |
| 35–37 y | 3 | 4 | |
|
| |||
| Race and ethnicity | 0.11 | ||
|
| |||
| White, Non-Hispanic | 69 | 81 | |
| Black, Non-Hispanic | 14 | 8 | |
| Hispanic or Latino | 17 | 8 | |
| Other | 0 | 4 | |
|
| |||
| Cancer therapy | |||
|
| |||
| Chemotherapy | |||
| Anthracycline | 66 | 80 | 0.09 |
| Cyclophosphamide | 39 | 46 | 0.45 |
| Dexamethasone | 14 | 4 | 0.37 |
| Cranial radiotherapy (CRT) | |||
| Any CRT | 38 | 29 | 0.42 |
| < 24 Gy | 9 | 10 | 0.28 |
| ≥ 24 Gy | 28 | 19 | 0.41 |
| Stem cell transplant | 5 | 8 | 0.70 |
| Total body irradiation | 5 | 8 | 0.70 |